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Abstract
This paper presents a review of imaging techniques and of their utility in system biology. During the
last decade systems biology has matured into a distinct field and imaging has been increasingly used
to enable the interplay of experimental and theoretical biology. In this review, we describe and
compare the roles of microscopy, ultrasound, CT (Computed Tomography), MRI (Magnetic
Resonance Imaging), PET (Positron Emission Tomography), and molecular probes such as quantum
dots and nanoshells in systems biology. As a unified application area among these different imaging
techniques, examples in cancer targeting are highlighted.
Systems biology
Systems biology [1-8] attempts to model the dynamics
and structure of complete biological systems. To accom-
plish this goal, it enlists concepts and expertise from a
wide array of fields such as mathematics, physics, engi-
neering, and computer science in addition to the biologi-
cal sciences. The "building blocks" of systems biology
models are knowledge and data produced within experi-
mental biology, and mathematical modeling provides the
"cement" that links these "building blocks." Systems biol-
ogy extensively uses computational technology and
numerical techniques to simulate complex biological net-
works. The goal is not only to describe biology on a single
component level, but also to understand system proc-
esses, mechanisms, and principles. The insight gained
from simulation results can then be used to design in vivo
and in vitro experiments, and in turn further develop mod-
els in an ever more refined description of physical and
biological reality.
As seen in Figure 1, experimental biology can be aided by
data mining, and thus statistical analysis, which can be
used to extract hidden patterns from large quantities of
data to form hypotheses. Hypothesis-driven models can
then describe system dynamics. In this regard, systems
biology includes in silico simulations in addition to in vitro
and in vivo experiments. With adequate models of biolog-
ical function it is possible to use control methods, as in
incorporating feedback and regulatory loops into models
and system understanding. Imaging plays a unique role in
that it can both provide insight during experiments and
also be used to gather data in a high throughput fashion
for later analysis.
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There are two approaches or "avenues" describing the
interplay between experimental and theoretical biology.
The traditional approach has been for experimental
results to drive model creation. An alternative approach is
to generate models based on first principles and then test
model-inspired hypotheses by new experiments. The ideal
situation is to traverse both "avenues," and so central to
the methodology of systems biology is the notion of an
iterative and strategic interplay between experimentation
and modeling [1,3,5,6,8-11].
Role of imaging
Since the time of Galileo, imaging has been the "eyes of
science." Modern imaging technologies allow for visuali-
zation of multi-dimensional and multi-parameter data.
Imaging is increasingly used to measure physical parame-
ters such as concentration, tissue properties, and surface
area [12] and to glean temporal insight on biological
function. Molecular probes can also be employed to allow
for both therapeutic and diagnostic applications [13-16].
As the spatial resolution and acquisition frequency of
imaging techniques increase, using imaging to monitor
substrate and protein dynamics in real time may be more
readily achieved. Data acquired by imaging can provide
the basis for mathematical modeling of protein kinetics
and biochemical signaling networks [12,17]. Imaging can
also be a suitable means to test computational models
already developed.
Digital image processing techniques such as segmentation
and registration contribute to model creation and valida-
tion strategy. Segmentation can help outline and identify
particular regions in an imaged volume where there is bio-
logical activity of interest taking place. Registration can
assist in the alignment of imaged volumes and areas
acquired at different times. Segmentation and registration
used together can generate time series data for validating
systems biology models. After segmentation and registra-
tion, volume and surface rendering can be employed for
data visualization [12]. Implementing systems biology
models in conjunction with imaging provides a way to
refine understanding of biological systems [18]. Eventu-
ally, as imaging tools become more widely used, and as
more biological processes are understood, systems biol-
ogy models can be developed that will have true predic-
tive capabilities. To reach this end biology will be
propelled by computational models, and imaging science
will guide their formulation and validation.
Cancer applications
Major efforts are underway to apply systems biology
methods to oncology [19,20]. Increasingly sophisticated
and accessible genomics, proteomics, and metabolomics
high throughput experiments provide a basis for new
types of oncology research [21]. The number of published
results based on gene expression microarray data alone
has increased by a factor of 1700% over the last decade
[22]. These advances in experimental systems biology
coupled with new analysis techniques and quantitative
imaging software tools are helping to generate a more
complete picture of many cancer related signaling path-
ways [21-23].
The actual development of cancer is a complex process,
requiring the accumulation of multiple independent
mutations each governing different pathways of cell
growth and the cell cycle [21,24]. Genome-wide experi-
ments have shown many signaling pathways to be interre-
lated and with many transcription factors serving as co-
regulators in other signaling pathways [21,24,25]. This
integrated nature of cancer pathways leads to difficulty in
targeting specific pathway components. Efforts are under-
way to create comprehensive models of the cell cycle that
can be used to better understand both the dynamics of
cancer and to enable the design of targeted therapeutics
[21,24,26].
Components of systems biology Figure 1
Components of systems biology. Systems biology sup-
plements experimental biology by providing methods to both 
interpret and validate new findings. Data mining provides a 
way to gain insight from large data sets, while control meth-
ods facilitate the interplay of modeling and experimental biol-
ogy. Imaging can be used for qualitative assessments during 
experiments and also provide a large amount of data amena-
ble for data mining.BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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Advances in molecular imaging can help to satisfy the
post-genomic era need for the study of complete biologi-
cal pathways, and this can potentially accelerate the
achievement of a systems level understanding of biologi-
cal complexity [27,28]. Molecular imaging enables the
determination of both the temporal and the spatial distri-
butions of biological processes throughout an intact liv-
ing subject. With this approach, it is possible to obtain
more meaningful results than can be achieved by compa-
rable in vitro methods [29].
With the advance of molecular imaging techniques, prop-
erly tagged molecules can be visualized leading to insights
on cell function, membrane binding sites, and the effec-
tiveness of particular therapies [30-33]. For example, inte-
grating imaging and modeling has led to successful
monitoring of immune system functionality via T cell
activity [10] and the development of bacteriophages for
cancer targeting [34]. It is this type of integration of imag-
ing and modeling that can enable new advances in oncol-
ogy and other fields in the biomedical sciences.
Imaging on multiple scales
The next generation of imaging tools will include innova-
tive microscopy methods, ultrasound, CT (Computed
Tomography), MRI (Magnetic Resonance Imaging), and
PET (Positron Emission Tomography). In the coming
years, improvements in temporal sampling and spatial
resolution will certainly continue. With the advent of
molecular probes, imaging can be conducted not only to
visualize gross anatomical structures, but also to visualize
substructures of cells and monitor molecule dynamics.
Thus, the imaging modalities of microCT, microMRI,
fMRI, MRS, microPET will also play important roles. A
comparison of these imaging technologies is summarized
in Table 1. As for the organization of this review paper,
each imaging technique is profiled with its respective
underlying principle, a description of selected current
applications, and a discussion of advantages and known
limitations. As a common application area, topics in can-
cer targeting are highlighted.
Microscopy
Basic principles
The advent of fluorescence microscopy has been a major
step forward in the study of living cells. Leveraging the
characteristic emissions of excited biological fluoro-
phores, such as fluorescent proteins, it is possible to gain
insight on cell structure and function (Figure 2). Follow-
ing traditional fluorescence microscopy has been the
development of multi-photon methods, where fluoro-
phores are excited by two or more photons [35]. Multi-
photon absorption is achieved with a single pulsed laser
focused to a diffraction-limited spot on the specimen.
With higher peak power, there is an increase in probabil-
ity for multi-photon absorption leading to fluorophore
excitation. Two-photon fluorescence is depicted in Figure
3a. To meet the excitation energy in this case, two 800 nm
photons are used. One 400 nm photon is of equivalent
energy, as can be used in single photon excitation, but
with multi-photon methods only the area of the laser
focus on the specimen is excited. Due to more focused
excitation, there is a lower overall phototoxic effect. Also,
as scattering of longer wavelength photons is less, multi-
Table 1: Comparison of imaging technology for systems biology
Imaging Technique Resolution References Spatial Resolution Scan Time Contrast Agents and 
Molecular Probes
Key Use
Multi-photon Microscopy [29,38] 15 – 1000 nm Secs Fluorescent proteins, dyes, 
rhodamine amide, quantum 
dots
Visualization of cell 
structures
Atomic Force Microscopy [104] 10 – 20 nm Mins Intermolecular forces Mapping cell surface
Electron Microscopy [41] ~5 nm Secs Cyrofixation Discerning protein 
structure
Ultrasound [29] 50 μm Secs Microbubbles, nanoparticles Vascular imaging
CT/MicroCT [29,70] 12 – 50 μm Mins Iodine Lung and bone tumor 
imaging
MRI/MicroMRI [29,76] 4 – 100 μm Mins – Hrs Gadolinium, dysprosium, 
iron oxide particles
Anatomical imaging
fMRI [105] ~1 mm Secs – Mins Oxygenated hemoglobin 
(HbO2) deoxygenated 
hemoglobin (Hb)
Functional imaging of brain 
activity
MRS [106,107] ~2 mm Secs N-acetylaspartate (NAA), 
creatine, choline, citrate
Detection of metabolites
PET/MicroPET [29,108] 1 – 2 mm Mins Fluorodeoxyglucose (FDG), 
18F, 11C, 15O
Metabolic imaging
The various micro versions of the imaging modalities (MicroCT, MicroMRI, MicroPET) as well as the microscopy techniques (Fluorescence, Multi-
photon, Atomic, Electron) are primarily used in either cellular or animal studies. The remaining modalities (Ultrasound, CT, MRI, MRS, PET) are 
more widely used clinically.BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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photon methods have deeper penetration when com-
pared to single photon excitation.
In STED (Stimulated Emission Depletion) microscopy
[36,37], two pulsed lasers are used in tandem to break the
diffraction barrier. The first laser pulse has a wavelength
that excites fluorophores, and is immediately followed by
a second laser pulse that depletes fluorescence. The fluo-
rescence depletion is achieved as the wavelength of the
second laser is tuned to be longer than the fluorescence
emission. Absorption of a photon from the second laser
induces electrons to drop to a lower energy level (stimu-
lated emission) preventing typical fluorescence. The dif-
ference in area of the two focused beams leaves only a very
small area from where fluorescence is detected. This area
is smaller than a diffraction-limited spot. Using STED,
images have been captured with a resolution of ~30 nm
[35]. In another study using rhomadine amide and a pho-
toswitching technique, a resolution of 15 nm was
achieved [38]. In [39,40], an optical trapping system was
used to make angstrom resolution measurements of pair
based stepping of RNA polymerase, and thus has estab-
lished an important resolution benchmark in molecular
biology.
Electron microscopy has offered a resolution of ~5 nm for
imaging biological tissue [41]. However, to prepare a sam-
ple to be imaged by an electron microscope is a rigorous
process that does not allow for imaging of live samples
[42]. One common sample preparation technique is cry-
ofixation, which is a high pressure and deep freezing tech-
nique that results in contrast in electron microscopy [43].
Even though the samples are no longer viable, electron
microscopy has provided invaluable insights on the struc-
tural details of organelles and membranes [44].
Atomic force microscopes do not acquire information
optically, but rather by recording intermolecular forces
between a probe tip and a surface. The primary informa-
tion acquisition component of an atomic force micro-
scope is a cantilever with a nanometer-scale silicon tip.
The tip is brought in close proximity with the sample and
the deflection of the cantilever due to Van der Waals forces
is recorded to generate a contour map of the sample sur-
Fluorescent protein applications Figure 2
Fluorescent protein applications. (a) Three Madin-Darby canine kidney epithelial cells with GFP-rac1 and dsRed-E-cad-
herin. Rac1 is a pleiotropic signaling molecule that is closely associated with cell-cell adhesion and cell motility. E-cadherin is a 
cell-cell adhesion protein responsible for facilitating communication between two contacting cells. Scale bar: 10 μm. Contrib-
uted by Lance Kam (Columbia University, New York). (b) Membranes of human umbilical cord endothelial cells visualized using 
EYFP. Scale bar: 40 μm. (c) GFP-actin labeled human umbilical cord endothelial cell undergoing mitosis, with actin filaments 
aligned toward the centrioles. Scale bar: 30 μm. Contributed by Samuel Sia (Columbia University, New York).
ab
c
_______ _____
_____BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
Page 5 of 18
(page number not for citation purposes)
face [45,46]. In comparison with an electron microscope,
the sample does not need any special treatment that
would actually destroy the sample and prevent its reuse.
However, using contact or tapping mode of an atomic
force microscope, which impinges on the sample surface
to acquire measurements such as strain, can mechanically
damage cells and tissue. Other probe microscopy tech-
niques include scanning tunneling microscopy and near-
field scanning optical microscopy [47].
Current applications
Fluorescence microscopy is often used in systems biology
and there is a strong push for the development of high
throughput methods. In the application of genome-wide
RNAi screens to document the phenotype for each sup-
pressed gene [48,49], there can be millions of images
from a single screen which can amount to several tera-
bytes of data [50]. It is systems biology modeling that
relieves the bottleneck of processing this large amount of
RNAi screen image data by providing an efficient means of
classification. With high throughput microscopy there is
Two-photon microscopy of in vivo brain function Figure 3
Two-photon microscopy of in vivo brain function. (a) Basic mechanism of two-photon fluorescence. (b) Schematic of 
surgical preparation of exposed cortex, with sealed glass window and microscope objective positioning. Green dot shows loca-
tion of two-photon fluorescence. (c) Examples of two-photon maps of the vasculature following intravenous injection of dex-
tran-conjugated fluorescein. Black dots and stripes show red blood cell motion. (d) Dual-channel imaging of neuronal (green) 
and vascular (red) signals: (left) Oregon Green 488 BAPTA-1 AM calcium sensitive dye stained neurons and (right) transgenic 
mouse expressing green fluorescent protein (GFP) in a subpopulation of neurons (mouse supplied by Jeffrey M. Friedman, 
Rockefeller University, New York) [101]. Texas dextran red is the intravascular tracer in both cases. (e) Three channel imaging 
of Tg2576 APP Alzheimer's disease mouse model with amyloid-targeting dye (blue), GFP expressing neurons and dendrites 
(green) and vasculature (red). Adapted from [52] and contributed by Elizabeth Hillman (Columbia University, New York).BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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much more data generated than can be annotated or eval-
uated manually, and so developing a fine-tuned and effi-
cient classification model is paramount for unlocking the
potential of high throughput methods.
As seen in Figure 2, fluorescent proteins can be used to vis-
ualize many functional and structural aspects of cells.
Using multi-photon methods as well can provide insight
on cell structural and biochemical changes [51]. Multi-
photon methods have a wide array of applications includ-
ing in vivo brain imaging in animals (Figure 3) [52-54],
where cortical micro-architecture has been investigated
with single cell resolution [55]. Electron microscopes have
been used to elucidate macromolecule structure [41]. As
for cancer applications, atomic force microscopes have
been used to monitor the super-coiled state of DNA,
which is preferential to the binding of the tumor suppress-
ing protein p53 [56]. Also in regard to detecting levels of
p53 in cells, fluorescence microscopy has been used to
determine the effectiveness of oncolytic adenoviruses.
Specially designed oncolytic adenoviruses target cancer-
ous tissues and are programmed to replicate if the cellular
p53 level is low. Viral oncolytic therapy is an intense
research area for cancer treatment and as microscopy tech-
niques advance so will the ability to assess the effective-
ness of viral vectors for tumor ablation [57,58].
Advantages and limitations
It has been long held that the wave nature of light imposes
a seemingly fundamental limit on the resolving power of
a microscope. The limitation was approximately half the
wavelength of visible light or 200 nm. Recently, there has
been over a 10-fold resolution improvement with
advances in microscopy [35,38]. However, optical tech-
niques have limited penetration as light readily scatters in
tissue. This can be partially ameliorated by using more
powerful lasers, but this in turn can lead to increased pho-
tobleaching effects which can limit the amount of time
that an experiment can run.
Microscopy, as with other modern imaging techniques,
has become ever more dependent on software for image
acquisition and analysis. Imaging technology can be
enhanced or limited by the software it is coupled with.
Table 2 contains an overview of current microscopy image
analysis software. With advances in acquisition algo-
rithms and optics holographic microscopy has been
achieved, by which full three-dimensional information
can be acquired in a single image [59,60]. As a result, vol-
umetric time series data can be collected without the need
of changing focus and scanning multiple z-planes.
Ultrasound
Basic principles
Ultrasound imaging entails moving a hand held probe
over the patient and using a water-based gel to ensure
good acoustic coupling. The probe contains one or more
acoustic transducers and sends pulses of sound into the
patient. Whenever a sound wave encounters a material
with different acoustical impedance, part of the sound
wave is reflected which the probe detects as an echo. The
time it takes for the echo to travel back to the probe is
measured and used to calculate the depth of the tissue
interface causing the echo. The greater the difference
between acoustic impedances, the larger the echo is. A
computer is then used to interpret these echo waveforms
to construct an image [61].
Current applications
Ultrasound has had a tremendous impact in cardiology.
As seen in Figure 4, the use of ultrasound can enable the
coupling of anatomical and strain information of the
heart [62]. Going from the organ level to the molecular
level has been made possible by advances in microbubble
manufacturing. Microbubbles themselves are several
micrometers in diameter and are intravascular tracers
[63]. Ligands can be attached to microbubbles to make
them target specific [64]. Many clinical applications of
contrast enhanced ultrasound, such as monitoring angio-
genesis and inflammatory response, rely on ultrasound
detection of microbubbles that contain gas. Since micro-
bubbles are confined to the vascular space, they are useful
for targeting antigens expressed on endothelial and blood
cell surfaces [63]. Smaller nanoparticle based contrast
agents are also available that are capable of extravascular
migration in regions of vascular injury or regions where
vascular permeability is abnormally high. Ultrasound can
also cause a mechanical interaction with microbubbles,
leading to their destruction and the subsequent release of
therapeutic compounds [65].
In tumor and angiogenesis models, surface expression of
αvβ3 has been demonstrated to be a strong ligand for tar-
geting endothelial cells in angiogenic vessels [63]. In
order to image this surface expression, microbubbles were
conjugated with peptides that bind to αvβ3. These micro-
bubbles have been shown to have a binding preference to
the endothelial surface of Fibroblast Growth Factor (FGF)
stimulated neovessels. The extent of neovascularization in
a matrigel model matched the image enhancement in
ultrasound images to a large extent. Thus, ultrasound
imaging served to help validate this experimental model
for angiogenesis [63].
Advantages and limitations
The signal-to-noise ratio for ultrasound images is much
lower with nanoparticles than those using microbubbles.BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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Although microbubbles are restricted to the vascular
space, this can be an advantage since it minimizes poten-
tial signal interference from nonvascular cells [63]. As
with other molecular imaging techniques, there is an
inverse relationship between sensitivity and resolution for
contrast enhanced ultrasound. The relative rate of
unbound tracer clearance is also an important issue that
determines temporal resolution. In this regard, with clear-
ance time within minutes, microbubble tracers are ideal
[63].
CT/MicroCT
Basic principles
Intrinsic differences in X-ray absorption among water,
bone, fat, and air provide contrast in Computed Tomog-
raphy (CT). In CT, a low energy X-ray source and a detec-
tor rotate around the subject, acquiring volumetric data.
The detectors are typically Charged Coupled Devices
(CCD) and act to phototransduce incoming X-rays [66].
For animal studies, microCT machines can be used which
typically operate with higher energy X-rays when com-
pared to human scanners. The increase in energy
improves resolution, but exposes the specimen to more
ionizing radiation which has adverse health effects.
Table 2: Overview of microscopy image analysis software
Vendor Package Name Image Support Supported Devices Website
MVIA Image Analysis Software 2D/3D A http://www.mvia.com
Clemex Clemex Vision PE 2D/3D A http://www.clemex.com
MIS Pax-It PI-M300A 2D E http://www.paxit.com
Media Cybernetics Image-Pro Bundled Solutions
Image-Pro AMS
Image-Pro MDA
Image-Pro MC
Image-Pro 3D Suite
2D/3D A, D http://www.mediacy.com
iMTtechnology iSolution DT 2D/3D n/a http://www.imt-digital.com
Dewinter Optical Dewinter Caliper Pro
Dewinter Biowizard
Dewinter Material Plus
Dewinter Foundry Plus
Dewinter Micro Measurement Pro
2D E http://www.dewinterindia.com
MBF BioScience MicroBrightField AutoNeuron
Confocal SD
ImageStackModule
NeuroLucida
SolidModelingModule
SteroInvestigator
VirtualSliceModule
2D/3D C, D, E http://www.mbfbioscience.com
Nascent Technology MedicalPlus
MeasurePro
CapturePro
2D A http://www.nascentimage.com
Intelligent Perception Pixcavator Image Analyzer 2D n/a http://inperc.com
GSA Bansemer & Scheel GbR GSA Image Analyser 2D n/a http://www.gsa-online.de
Broad Institute CellProfiler*
CellVisualizer*
2D n/a http://www.cellprofiler.org
IMAS CellObserver
EliSpot
Process
Analysis
2D A, D, E http://www.imas.co.uk
Wadsworth Center Spider* 2D/3D E http://www.wadsworth.org
MCID MCID Core 2D/3D A, E http://www.mcid.co.uk
ImageJ ImageJ for Microscopy* 2D/3D C, D http://www.macbiophotonics.ca
Scion Corporation Scion Imaging Software* n/a n/a http://www.scioncorp.com
(*) Open source/freeware software packages
A = Automated microscope
B = Planar microscope
C = Confocal microscope
D = Functional microscope
E = Digital microscope
Gaining insight from microscopy images typically requires some level of processing and analysis. Both commercial and open source software 
packages are available that can supplement or totally drive microscope usage.BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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Current applications
CT has relatively low soft tissue contrast for tumors and
surrounding tissue, but with iodinated contrast agents
organs and tumors can be detected [29]. As a result, incor-
porating iodine into new probes for CT imaging may be
necessary. Furthermore, to detect a tumor or other target
there must be sufficient site-specific accumulation of
probes to result in attenuation of X-rays. With differential
attenuation of X-rays, the target can be more readily delin-
eated [7].
CT can be used to image lung tumors and bone metasta-
sis, given its fast imaging time and high spatial resolution.
High throughput techniques using microCT have been
used for phenotyping large numbers of transgenic mice
and detecting macroscopic abnormalities [64]. In [67],
the co-registration of microCT images containing tumor
structural details with bioluminescence images allowed
for the study of cell trafficking, tumor growth, and
response to therapy in vivo. This image analysis method
could potentially be used for assessing hematological
reconstitution following bone marrow transplantation.
As seen in Figure 5, microCT imaging and volumetric
decomposition were used to provide insight on trabecular
bone microarchitecture [68]. The bone samples were
decomposed into individual plates and rods, and this
imaging and processing scheme has been successfully
applied to anatomic sites such as the proximal femur,
proximal tibia, and spine. Several key morphological fea-
tures of trabecular bone architecture were studied: plate
and rod size, thickness, number density, and orientation.
With this level of detail, it was determined that trabecular
plates play an essential role in determining the elastic
Transthoracic echocardiography and elastography of a healthy human left ventricle Figure 4
Transthoracic echocardiography and elastography of a healthy human left ventricle. (a), (b), (c), and (d) are the lat-
eral, axial, radial, and circumferential systolic strains from myocardial elastography between end diastole and end systole, 
respectively. Strains are displayed on a scale of ± 50%. All the images were acquired approximately at the papillary muscle level 
and shown at end systole. Contributed by Elisa Konofagou (Columbia University, New York).
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properties of trabecular bone [68]. Assessing such proper-
ties can be important for gauging bone health in condi-
tions such as osteoporosis, and for designing viable
replacement tissue in tissue engineering applications [69].
Advantages and limitations
A key advantage of CT is its high spatial resolution, 12 –
50 μm [29,70], which is needed to visualize fine anatom-
ical details. CT can also be combined with functional
Complete volumetric decomposition procedure on a vertebral trabecular bone sample Figure 5
Complete volumetric decomposition procedure on a vertebral trabecular bone sample. (a) Example microCT 
bone volumetric data. (b) Closer view of plate and rod microstructures. (c) MicroCT image of a trabecular bone sample. (d) 
Completely decomposed trabecular bone structures with individual trabeculae labeled by color for each voxel. Image volume: 
5 mm3. Contributed by X. Edward Guo (Columbia University, New York).
b a
c dBMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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imaging technologies that provide dynamic and meta-
bolic information. The radiation dose of CT, however, is
not negligible and this limits repeated imaging in human
studies due to health risks [64].
MRI/MicroMRI, fMRI, and MRS
Basic principles
Magnetic Resonance Imaging (MRI) is achieved by plac-
ing a subject in a strong magnetic field, typically 1.5 or 3
Tesla for human scanners, which aligns the hydrogen
nuclei spins in a direction parallel to the field. A Radio
Frequency (RF) pulse is applied to the sample which
causes the spins to acquire enough energy to tilt and
precess, where an RF receiver can record the resulting sig-
nal [71]. After the removal of the RF pulse, the spins rea-
lign parallel to the main magnetic field with a time
constant of T1 which is tissue dependent. Signal strength
decreases in time with a loss of phase coherence of the
spins. This decrease occurs at a time constant T2 which is
always less than T1. Magnetic gradients are used to local-
ize spins in space, enabling an image to be formed. The
difference in spin density among different tissues in a het-
erogeneous specimen enables the excellent tissue contrast
of MRI [71]. MicroMRI follows the same principles, but a
much higher magnetic field strength is used for animal
studies. Increasing magnetic field strength improves reso-
lution, but can disturb the visual system and lead to
peripheral nerve stimulation.
Functional Magnetic Resonance Imaging (fMRI) is a
modality used to image brain activity in response to spec-
ified stimuli. When a stimulus solicits a response from a
certain area of the brain, metabolism in that region
increases. Metabolic demand leads to an increase in blood
flow and more oxygenated hemoglobin in the region. As
the supply of oxygenated hemoglobin exceeds the meta-
bolic demand, the concentration of oxygenated hemo-
globin increases. The balance between oxygenated and
deoxygenated hemoglobin is altered leading to a change
in image contrast. To detect a change, the image is com-
pared with baseline measurements. Typical cortical activa-
tion leads to a 1 – 5% increase in image intensity [72].
Magnetic Resonance Spectroscopy (MRS) is an emerging
imaging and biochemical analysis technique in biomedi-
cal science. It combines the analytical ability of Nuclear
Magnetic Resonance (NMR) to identify biochemical spe-
cies with the capabilities of MRI to isolate individual vox-
els which are three-dimensional pixels. MRS employs
chemical shift imaging to localize spectra for individual
voxels [73]. This is achieved by phase modulated RF
pulses which eliminate signal contamination into neigh-
boring voxels. When MRS is combined with MRI, concur-
rent anatomical and biochemical information is obtained
(Figure 6).
Current applications
The range of microMRI applications spans from purely
experimental to preclinical. MicroMRI technology has
been used to track stem cells, monitor immune cell prolif-
eration, and describe embryological development [74]. It
has also been used to obtain three-dimensional high res-
olution representations of bone structure [75]. MicroMRI
has advanced to the point at which individual cells, and
their organelles, can be imaged with spatial resolution of
<4 microns. Images of a paramecium and a spirogyra alga
were acquired utilizing a magnetic field of 9 Tesla, phase
encoding in all three axes (which improves signal to
noise), and Carr-Purcell echo refocusing (incorporation
of multiple 90 degree spin echo pulses into the sequence
to minimize signal loss due to sample inhomogeneity)
[76].
Contrast agents have been developed with greater affinity
for cellular and molecular targets. These include iron
oxide particles (which have been used to label individual
T cells), manganese ions (which act as a paramagnetic sur-
rogate of calcium), and caged compounds. The latter
involves chelated gadolinium surrounded by an enzyme
In vivo point resolved (single voxel) MRI spectroscropy Figure 6
In vivo point resolved (single voxel) MRI spectro-
scropy. (a) Axial and (b) sagital views of human brain and 
outlined voxel for MRS. (c) 1H spectrum with readily visible 
N-acetylaspartate (NAA) peak. An aberrant NAA peak can 
be an indicator of brain injury or disease.BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
Page 11 of 18
(page number not for citation purposes)
substrate, which physically obstructs water molecules
from approaching the gadolinium. When an enzyme
cleaves the substrate, water is able to approach the gado-
linium. This in turn reduces T1 and increases contrast. The
caged-compound technique has been used to demon-
strate regionalized in vivo gene expression in frog embryos
whereas manganese ions have been used to trace neuronal
pathways [74].
fMRI is used to study the functions of the living brain in a
non-invasive manner. It has been shown with fMRI that
different cognitive functions, such as attention, percep-
tion, imagery, language, and memory, elicit specific cogni-
tive activation patterns in different regions of the brain.
One common clinical use of fMRI is in the treatment of
patients with brain tumors, and a primary treatment goal
is to preserve functional brain tissue. fMRI is used to deter-
mine the functionality of brain tissue surrounding the
tumor so that potentially harmful therapy can be directed
away from critical areas [77].
Due to the ability of MRS to identify the presence of mol-
ecules within voxels, many studies have been devoted to
using it to help diagnose cancer and characterize neoplas-
tic tissue. Currently, MRS has been successfully employed
in regard to brain, breast, and prostate cancer through
identification of various biochemical markers of neo-
plasm in the imaged volume [78,79]. 1H has been the ele-
ment of choice because of its large abundance, but studies
involving  31P and 13C appear promising. The latter has
been used as an effective dynamic marker of metabolic
processes through a hyperpolarization technique [80].
Advantages and limitations
The two chief advantages of MRI are its excellent tissue
contrast and lack of ionizing radiation [74]. Improved sig-
nal-to-noise ratio and resolution can be obtained via a
small receiver coil radius and high magnetic field strength.
However, high magnetic field strength is problematic in
human applications because of arising physiological
effects such as nausea and visual abnormalities. Also,
higher field strength leads to other technical challenges
including an increase in the operating frequency, which
potentially generates artifacts.
The main advantage of fMRI is its ability to non-invasively
image brain. Since image contrast is achieved through the
levels of oxygenated and deoxygenated hemoglobin, no
external contrast agent is needed. However, due to the
faster temporal resolution needed to acquire images of
dynamic brain activity, spatial resolution is reduced.
Due to the ability of MRS to reveal the presence of partic-
ular biomedical molecules and compounds within an in
vivo sample, it seems ideally poised for use in systems
biology research. However, certain challenges must be
overcome such as large voxel size, long sampling times,
and questionable quantitative accuracy of assessing
molecular concentrations [81].
PET/MicroPET
Basic principles
In Positron Emission Tomography (PET), radioactive trac-
ers are incorporated into metabolically active molecules
and then injected intravenously. There is a waiting period
while the metabolically active molecules are concentrated
in the target tissue. The molecule most commonly used in
PET is fluorodeoxyglucose (FDG), which has radioactive
fluorine and is readily taken up by tumors. The radioactive
tracer decays and produces two 511 keV gamma-rays,
which result from the annihilation of a positron and an
electron. The two resultant gamma-rays are emitted nearly
180 degrees apart and observed by detector rings. Figure 7
contains several sample PET images. The sensitivity of PET
at detecting molecular species is relatively high, in the
range of 10-11 – 10-12 M. For animal studies, microPET has
a volumetric resolution of 8 mm3, while next generation
scanners have over an 8-fold increase in resolution and a
field of view that encompasses the whole body of a mouse
[29,82].
Phantom and anatomical PET images Figure 7
Phantom and anatomical PET images. (a) 11C PET 
image of a rod phantom. (b) FDG PET image of a brain. (c) 
Coronal view of thoracic area from a whole body PET scan.
a b
cBMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
Page 12 of 18
(page number not for citation purposes)
Current applications
There are many radioactive tracers for PET that are used in
different preclinical and clinical applications [7]. The trac-
ers that target specific tumors are essential for systems
biology studies due to the information provided regarding
metabolic activity [83,84]. Examples of small targeting lig-
ands include 11C-labelled N-methylspiperone and 18F-
labelled spiperone for targeting dopamine receptors on
pituitary adenomas [83].
PET is useful in systems biology studies related to bone
metabolism [85] and metastasis. Bone metastasis is com-
mon for several cancers, including prostate, breast, and
lung [86]. 15O-labelled water can be extracted from the
blood and used to assess tumor blood perfusion. Tumors
are in constant need of nutrients from the blood, and
tumor neovascularization provides a crucial lifeline for
rapidly dividing tumor cells. The uptake of tracer into tis-
sues is proportional to delivery, and so is a measure of per-
fusion [87].
PET can be used for measuring therapeutic effects on dis-
ease processes. Specific metabolic enzymes that are selec-
tively expressed in prostate cancer cells constitute such a
target. In [11], genes that were differentially expressed
between early stage and late stage prostate cancer were
studied. L-lactate dehydrogenase-A catalyzes the forma-
tion of pyruvate from S-lactase and was expressed at a
high level in the late stage cancer cells. PET tracers based
on this process would serve to validate this finding and
may allow for the identification of prostate cancer metas-
tasis [11].
Advantages and limitations
PET is a highly sensitive, minimally-invasive technology
that is ideally suited for pre-clinical and clinical imaging
of cancer biology. By using radioactive tracers, three-
dimensional images can be reconstructed to show the
concentration and locations of metabolic molecules of
interest [2]. Since the study of cancer cells in their normal
environment within intact living subjects is essential, PET
is ideally suited for monitoring molecular events early in
the course of a disease, as well as during pharmacological
or radiation therapy. Furthermore, it can be used to
acquire prognostic information and to image for disease
recurrence [2,82].
PET spatial resolution is comparatively poor, and is lim-
ited by pixel sampling rate, the source size, and blurring
in the phosphor screens of the detector rings. Another lim-
itation of PET is that radioisotopes with very short half
lives must be immediately injected after production. Due
to the same decay type of the different radioactive tracers,
it is only possible to trace one molecular species in a given
imaging experiment or clinical scan [64].
Molecular probes
Achieving contrast is essential to imaging technology and
is often made possible by contrast agents or molecular
probes. As mentioned above, fluorescent proteins have
played a key role in microscopy studies providing insight
on cell structure. Microbubbles have greatly enhanced the
use of ultrasound both in imaging and therapeutic appli-
cations. For CT, iodine has been instrumental in differen-
tiating tissue types. In MRI based technologies,
manipulation of hydrogen spins has allowed for excellent
soft tissue contrast and functional imaging of the brain.
FDG and other radioactively labeled tracers have enabled
targeting of cancer and imaging of metabolic activity with
PET. Below, two promising molecular probes are profiled,
quantum dots and nanoshells, which may yield a new
array of imaging applications.
Quantum dots
Basic principles
Quantum dots (QD) are a class of polymer-encapsulated
and bioconjugated probes that can fluoresce at multiple
wavelengths spanning the visible spectrum. Larger quan-
tum dots emit red light while smaller ones emit blue light.
Quantum dots themselves are comprised of a semicon-
ductor core, encased in another semiconductor material
that has a larger spectral band gap. This construction ena-
bles fluorescence upon excitation. Quantum dots can be
packaged in amphiphilic polymers and conjugated with
targeting ligands for imaging applications [88]. Under
harsh conditions such as wide pH range (1–14), varied
salt conditions (0.01 to 1 M), and a strong corrosive envi-
ronment (1.0 M hydrochloric acid), quantum dots dem-
onstrate extraordinary resiliency and sustained
functionality [14].
Current applications
Figure 8 shows the proliferation of human Mesenchymal
Stem Cells (hMSC) that are labeled with quantum dots.
After 22 days the quantum dots remained incorporated in
the hMSCs. This study suggests that bioconjugated quan-
tum dots are a viable probe for long-term labeling of stem
cells [89].
Ligands on quantum dots can be tailored to target specific
cancer lines. Quantum dots fashioned to target prostate
cancer, QD-PSMA (Prostate Specific Membrane Antigen),
showed active emission in the presence of C4-2 prostate
cancer cells while other quantum dots did not [14]. Quan-
tum dots can also be used to passively target tumors since
leaky tumor vasculatures retain more quantum dots than
surrounding healthy tissue. Thus, by both active binding
and passive diffusion, more quantum dots will be present
near cancerous tissue [14]. With the targeting capabilities
of quantum dots there is potential for use as a delivery
vehicle for therapeutic compounds. Delivery schemes canBMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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Quantum dot labeled human mesenchymal stem cells undergoing proliferation Figure 8
Quantum dot labeled human mesenchymal stem cells undergoing proliferation. hMSCs were incubated for 16 hrs 
in a 30 nM solution of bioconjugated QDs (a-a2). Following the removal of extracellular QDs, QD-labeled hMSCs and unla-
beled hMSCs of the same subpopulation were continuously cultured for 4, 7 and 22 days (b-b2, c-c2, d-d2, respectively). Scale 
bar: 30 μm. QDs were internalized in the cytoplasm, even after 22 days of culture-expansion (e-e2), apparently endocytosed as 
aggregates. Scale bar: 5 μm. Reproduced from [89] and contributed by Jeremy Mao (Columbia University, New York).BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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be based on the release of a therapeutic compound trig-
gered by ligand binding [13,14,16,90]. As an example of
a drug delivery application, in [91] quantum dots with
cadmium sulfide were used as chemically removable caps
inside mesoporous silica nanospheres to prevent the pre-
mature release of drug molecules. Targeted release of drug
molecules was mediated by disulfide bond-reducing
agents. Quantum dots could also be used in photody-
namic therapy by which there is an energy transfer from
the quantum dots to target cells, leading to the generation
of reactive oxygen species, and thus potentially inducing
apoptosis [92,93]. One limitation of such a therapy in vivo
would be reliable and localized energy transfer to ensure
the destruction of specific cells.
As applied to bacteriophage development, quantum dots
can be multi-purpose by validating the design model as
well as showing the effectiveness of tumor targeting [34].
One design model for bacteriophages with quantum dots
is based upon the characteristics of quantum dots them-
selves. These are namely durability due to the co-polymer
shell and flexibility due to the possibility of several differ-
ent ligands. Experiments have been conducted with quan-
tum dot embedded bacteriophages in both in vitro and in
vivo with the goal of destroying cancerous tissues. Itera-
tively designing and creating bacteriophages is an exam-
ple where quantum dots provide both the effective
targeting means, but also the validation of the design
model due to visualization of ligand binding [34].
Advantages and limitations
Information acquired by using quantum dots are con-
strained by the physical limits of fluorescence microscopy,
since that is the imaging technique typically used when
detecting emissions from quantum dots. There have been
some studies using quantum dots in electron microscopy,
which has an order of magnitude higher resolution than
light microscopy [90]. The quantum dots themselves
experience "blinking," as in each quantum dot randomly
switches from on to off. Fortunately, the fluorescence of a
bound quantum dot is stronger than of an unbound
quantum dot. Still, the randomness of "blinking" imposes
some limitations on applications requiring single mole-
cule detection as well as on applications requiring quanti-
fication of total fluorescence [13]. Using two different
color quantum dots, single molecule imaging has been
achieved by co-localization on target molecules [94].
Nanoshells
Basic principles
Nanoshells are a class of metal nanostructures consisting
of a dielectric silica core surrounded by a very thin metal-
lic shell. By varying the core to shell ratio and the overall
size of the nanoshells, strong scattering properties can be
achieved that result in resonance wavelengths generating
heat [15]. See Figure 9 for cross sectional views of a
nanoshell. Fabricating nanoshells with specific antibodies
provide a means for scattering based molecular imaging
[15,95], which provides molecule specific contrast on the
nanometer scale.
Current applications
As seen in Figure 10, nanoshells can facilitate tumor abla-
tion. In another cancer related study [15], nanoshells were
used as contrast enhancers to image HER2 expression, a
clinically relevant marker in human breast adenocarci-
noma cells. Gold nanoshells were fabricated and tuned
for Near Infrared (NIR) imaging. Then, the nanoshells
Near field images of an Ag nanoshell Figure 9
Near field images of an Ag nanoshell. Nanoshell exposed to (a) 721 nm, (b) 492 nm, and (c) 336 nm laser beam and con-
sequential dipole, quadrupole, and dark plasmons, respectively. Surface plasmon oscillations are collective electron motion 
resultant of optical illumination, and subsequent modes are shown. Adapted from [102].BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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were exposed to HER2 (specific) or IgG PEG-ylated (non-
specific) antibodies to facilitate targeting of cultured
human mammary adenocarcinoma cells. A microscope
equipped with a bright field and dark field were used to
evaluate cell viability. In vitro photothermal nanoshell
therapy was performed and silver staining demonstrated
the tissue targeting specificity of HER2 nanoshells as well
as the non-specificity of IgG nanoshells. In addition to
mediating photothermal destruction of breast cancer cells
in vitro, it was demonstrated that NIR absorbing nanoshell
bioconjugates can provide molecular specific optical con-
trast enhancement without cytotoxicity [15].
Advantages and limitations
Optical imaging with nanoshells offers the potential for
non-invasive, high resolution in vivo imaging at relatively
low cost [15]. Scattering based optical imaging technolo-
gies rely on inherent changes in indices of refraction. Strat-
egies that depend only on the intrinsic optical contrast
within tissue have proved clinically valuable in some
screening applications. However, such techniques are not
sensitive enough to resolve an image based on disease
biomarkers [15]. In cancer, when early detection is critical
to reducing morbidity and mortality, the use of molecule
specific contrast agents provides the ability to optically
sense and image abnormalities long before pathologic
changes occur at the anatomic level [15]. In the future,
nanoshells may provide excellent contrast for other imag-
ing modalities such as CT [96].
Conclusion
In this review we have assessed a range of imaging tech-
niques in systems biology spanning from microscopy to
clinical imaging. In addition to the techniques reviewed,
there are multiple other technologies that have lead to sig-
nificant contributions to a systems level understanding of
biological processes. Two such techniques are optical
coherence tomography [97,98] and hyperspectral imaging
[99,100]. With the refinement of current technologies and
the development of new techniques, additional informa-
tion will be available to help dissect biological systems.
As seen in Figure 11, there is a resolution gap between
microscopy and anatomical imaging. This gap also repre-
sents the divide between experimental and clinical imag-
ing applications. In contrast, acquiring anatomical and
metabolic information with clinical scanners has been
achieved by coupling imaging technologies. For example,
it is now commonplace for usage of combination PET/CT
scanners. This allows for metabolic information acquired
in PET to be readily registered with higher resolution ana-
tomical CT images. Also, with fMRI a slower MRI scan is
also conducted to form a detailed brain atlas, to which
functional images are later registered. As a result there is a
resolution continuum between anatomical and metabolic
imaging. To reach the same end for microscopy and ana-
tomical imaging, molecular probes such as quantum dots
and nanoshells may find more clinical applications and
thus improve the resolution that can be achieved with
clinical scanners.
Beyond improvements in resolution, a grand challenge
remains for the imaging technology development com-
munity: to enable dynamic imaging of both biological
system components and of their respective connections.
For example, the ability to resolve and monitor an entire
mammalian cortical circuit in vivo has yet to be realized.
Electrophysiology has been increasing complemented by
fMRI over the last 15 years, but with fMRI information on
neural activity is provided as an indirect measure and on
the scale of hundreds of thousands or millions of neu-
rons. Two-photon imaging has provided for single cell res-
olution, but functionally visualizing hundreds of
synapses performing computations is limited by axonal
labeling of neuronal populations and also by overall tem-
poral acquisition frequency. As a result, innovations in
methods for visualizing neural circuitry and for decipher-
ing spike times will be necessary to further advance sys-
Ablation of two tumors in a mouse Figure 10
Ablation of two tumors in a mouse. With exposure to 
an external infrared laser source, the nanoshells resonate 
and thermally destroy tumor cells and their respective vascu-
lature. Adapted from [103].BMC Systems Biology 2008, 2:74 http://www.biomedcentral.com/1752-0509/2/74
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tems neuroscience with imaging. In a broader set of
application areas, using imaging to simultaneously mon-
itor components of a molecular network will be useful in
further understanding cellular processes, such as apopto-
sis which is critical for the development of new cancer
treatments.
The further development of imaging technologies will
continue to be important in the advancement of systems
biology. Imaging can provide a wide array of data that can
be used to build and validate models. The information
acquired with imaging can be readily incorporated into
models as biochemical concentrations, functional activ-
ity, and anatomical coordinates. In addition, imaging pro-
vides data for new discoveries and diagnostic
information. Oncology and other areas in the biomedical
sciences will benefit greatly from imaging and systems
biology approaches.
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